464 related articles for article (PubMed ID: 18207653)
1. Immunohistochemical analysis of carcinomatous and sarcomatous components in the uterine carcinosarcoma: a case report.
Semczuk A; Skomra D; Chyzyńska M; Szewczuk W; Olcha P; Korobowicz E
Pathol Res Pract; 2008; 204(3):203-7. PubMed ID: 18207653
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in uterine carcinosarcoma: a clinicopathologic study of 25 patients.
Iwasa Y; Haga H; Konishi I; Kobashi Y; Higuchi K; Katsuyama E; Minamiguchi S; Yamabe H
Cancer; 1998 Feb; 82(3):512-9. PubMed ID: 9452269
[TBL] [Abstract][Full Text] [Related]
3. Carcinosarcoma of the uterus: immunohistochemical and genetic analysis of clonality of one case.
Watanabe M; Shimizu K; Kato H; Imai H; Nakano H; Sugawa M; Shiraishi T
Gynecol Oncol; 2001 Sep; 82(3):563-7. PubMed ID: 11520156
[TBL] [Abstract][Full Text] [Related]
4. Uterine carcinosarcoma: immunohistochemical studies on tissue microarrays with focus on potential therapeutic targets.
Cimbaluk D; Rotmensch J; Scudiere J; Gown A; Bitterman P
Gynecol Oncol; 2007 Apr; 105(1):138-44. PubMed ID: 17175012
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of P16 and P53 expression in uterine malignant mixed mullerian tumors.
Buza N; Tavassoli FA
Int J Gynecol Pathol; 2009 Nov; 28(6):514-21. PubMed ID: 19851197
[TBL] [Abstract][Full Text] [Related]
6. Carcinoma (malignant mixed müllerian [mesodermal] tumor) of the uterus and ovary. Correlation of clinical, pathologic, and immunohistochemical features in 29 cases.
Costa MJ; Khan R; Judd R
Arch Pathol Lab Med; 1991 Jun; 115(6):583-90. PubMed ID: 1710102
[TBL] [Abstract][Full Text] [Related]
7. High expressions of bcl-2 and survivin, and decreased apoptosis in uterine cervical carcinosarcoma compared to cervical squamous cell carcinoma.
Gan XL; Li JK; Yu TH; Zhang Y; Hu LN
Arch Gynecol Obstet; 2011 Jul; 284(1):175-81. PubMed ID: 20668868
[TBL] [Abstract][Full Text] [Related]
8. Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases.
Soslow RA; Ali A; Oliva E
Am J Surg Pathol; 2008 Jul; 32(7):1013-21. PubMed ID: 18469708
[TBL] [Abstract][Full Text] [Related]
9. AKT, EGFR, C-ErbB-2, and C-kit expression in uterine carcinosarcoma.
Saglam O; Husain S; Toruner G
Int J Gynecol Pathol; 2013 Sep; 32(5):493-500. PubMed ID: 23896716
[TBL] [Abstract][Full Text] [Related]
10. Malignant mixed mullerian tumor in a rabbit (Oryctolagus cuniculus): case report with immunohistochemistry.
Goto M; Nomura Y; Une Y; Goldschmidt MH
Vet Pathol; 2006 Jul; 43(4):560-4. PubMed ID: 16847001
[TBL] [Abstract][Full Text] [Related]
11. COX-2 expression in uterine carcinosarcoma.
Menczer J; Schreiber L; Sukmanov O; Kravtsov V; Berger E; Golan A; Levy T
Acta Obstet Gynecol Scand; 2010; 89(1):120-5. PubMed ID: 19900134
[TBL] [Abstract][Full Text] [Related]
12. [A case report of uterine carcinosarcoma with alpha-fetoprotein (AFP) production].
Shigemasa K; Myoga H; Nakanishi Y; Imajo M; Yorishima M; Matsuda H; Hung CC; Egawa K; Katsube Y; Fujiwara A
Gan No Rinsho; 1987 Feb; 33(2):223-9. PubMed ID: 2435929
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors and status of hormone receptors and angiogenic factors in uterine carcinosarcoma.
Etoh T; Nakai H
J Obstet Gynaecol Res; 2014 Mar; 40(3):820-5. PubMed ID: 24320058
[TBL] [Abstract][Full Text] [Related]
14. Bilateral ovarian malignant mixed Mullerian tumor in a dog.
Antuofermo E; Cocco R; Borzacchiello G; Burrai GP; Meloni F; Bonelli P; Pirino S; Cossu-Rocca P; Bosincu L
Vet Pathol; 2009 May; 46(3):453-6. PubMed ID: 19176505
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of the histogenesis of esophageal carcinosarcoma.
Wang ZY; Itabashi M; Hirota T; Watanabe H; Kato H
Jpn J Clin Oncol; 1992 Dec; 22(6):377-86. PubMed ID: 1283991
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry and K-ras sequence of pancreatic carcinosarcoma.
Nakano T; Sonobe H; Usui T; Yamanaka K; Ishizuka T; Nishimura E; Hanazaki K
Pathol Int; 2008 Oct; 58(10):672-7. PubMed ID: 18801090
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and immunohistochemical characteristics of esophageal carcinosarcoma.
Sano A; Sakurai S; Kato H; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Sakamoto K; Sano T; Hosoya Y; Enomoto T; Kanda T; Ajioka Y; Oyama T; Kuwano H
Anticancer Res; 2009 Aug; 29(8):3375-80. PubMed ID: 19661359
[TBL] [Abstract][Full Text] [Related]
18. Carcinosarcoma of the breast. Immunohistochemical and ultrastructural studies.
Alexiev B; Popov A
Zentralbl Pathol; 1992; 138(1):71-4. PubMed ID: 1375838
[TBL] [Abstract][Full Text] [Related]
19. CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.
Costa MJ; Guinee D
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):293-9. PubMed ID: 11127921
[TBL] [Abstract][Full Text] [Related]
20. Esophageal carcinosarcoma with basaloid squamous carcinoma and rhabdomyosarcoma components with TP53 mutation.
Amatya VJ; Takeshima Y; Kaneko M; Inai K
Pathol Int; 2004 Oct; 54(10):803-9. PubMed ID: 15482572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
